KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baozun (BZUN) Cash & Equivalents (2016 - 2024)

Historic Cash & Equivalents for Baozun (BZUN) over the last 11 years, with Q3 2025 value amounting to $158.1 million.

  • Baozun's Cash & Equivalents changed N/A to $158.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.1 million, marking a year-over-year change of. This contributed to the annual value of $176.6 million for FY2024, which is 4165.71% down from last year.
  • As of Q3 2025, Baozun's Cash & Equivalents stood at $158.1 million.
  • In the past 5 years, Baozun's Cash & Equivalents registered a high of $530917.0 billion during Q1 2022, and its lowest value of $153.78 during Q1 2025.
  • In the last 5 years, Baozun's Cash & Equivalents had a median value of $511.0 million in 2021 and averaged $38086.5 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 4689500.69% in 2021, then tumbled by 9999.99% in 2025.
  • Quarter analysis of 5 years shows Baozun's Cash & Equivalents stood at $720.5 million in 2021, then plummeted by 58.16% to $301.5 million in 2022, then fell by 0.97% to $298.5 million in 2023, then tumbled by 39.88% to $179.5 million in 2024, then decreased by 11.92% to $158.1 million in 2025.
  • Its Cash & Equivalents was $158.1 million in Q3 2025, compared to $166.0 billion in Q2 2025 and $153.78 in Q1 2025.